Goldline Pharmaceutical Reports H1 FY27 Results with 44.5% Net Profit Growth
Goldline Pharmaceutical Ltd · Financial Result · 15 Nov 2026, 1:11 am
Goldline Pharmaceutical Reports H1 FY27 Results with 44.5% Net Profit Growth Goldline Pharmaceutical reported standalone revenue from operations of ₹1,492.50 lakh for the half-year ended 30th Sep'26, up 7.4% YoY from ₹1,389.21 lakh in H1 FY26. Net profit rose 44.5% YoY to ₹205.15 lakh compared to ₹141.96 lakh, supported by higher operating profit and lower finance costs of ₹27.92 lakh versus ₹66.63 lakh. Basic and diluted EPS improved to ₹2.31 from ₹1.96. Total shareholder funds expanded significantly to ₹2,593.55 lakh from ₹1,424.96 lakh as of 31st Mar'26, following equity and share premium additions.
Original exchange filing (PDF)
More announcements from Goldline Pharmaceutical Ltd
- Submission of statement of deviation and variation of the half year ended 30th september 2026 · 15 Nov 2026
- Outcome of Board Meeting dated 14th November, 2026 pursuant to Reg 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 & Submission .... · 15 Nov 2026
- Goldline Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve The Standalone Unaudited .... · 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar · 02 Sept 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar · 02 Sept 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Laxmikant Mujumdar · 01 Sept 2026
- Scrutinizer Report · 31 Aug 2026
- AGM Proceedings of the 22nd Annual General Meeting (AGM) of the Company pertaining to Financial Year 2025-26. · 30 Aug 2026
